You just read:

Orexigen Announces Presentation of Data for OREX-1019 and OREX-1038, Preclinical Candidates for the Treatment of Chronic Pain with Reduced Addiction Liability and the Treatment and Management of Opioid Drug Addiction

News provided by

Orexigen Therapeutics, Inc.

Jul 10, 2017, 12:01 ET